Syncona LimitedSYNC.L
What Syncona Limited does.
Syncona Limited is a fund specializes in investments in hedge, equity and long-term alternative investment funds across multiple asset classes. It manages private equity, debt, fixed income and alternative investments. The fund prefers to invest in healthcare and life sciences sector with focus on Cell therapy, gene therapy, biologics and small molecules. The fund invests in the public equity and fixed income markets across the globe. It targets attractive medium to long term returns by investing in leading long-only and alternative investment funds with proven managers and across multiple asset classes. The firm invests in separately managed account portfolios.
Revenue and profit, by fiscal year.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Revenue | — | — | -£24.0M | £63.7M | -£68.3M | £55.9M |
| Net income | £53.2M | £8.8M | -£56.0M | £3.8M | -£143.2M | -£8.8M |
More on SYNC.L.
- Syncona Limited summary
- Syncona Limited financial statements
- Syncona Limited key metrics
- Syncona Limited health scores
- Syncona Limited valuation
- Syncona Limited dividends
- Syncona Limited peers
- Syncona Limited annual reports
Figures from Syncona Limited's annual reports (ESEF, via filings.xbrl.org) and Yahoo Finance, standardised automatically; prices are end-of-day closes. Not financial advice.